Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01029288 · ClinicalTrials.gov registry record · NA

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01029288: Completed NA study, sponsored by Mayo Clinic.

NCT01029288 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01029288, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The proposed trial seeks to determine the impact of patient decision aids versus usual care on measures of patient involvement in decision-making, diabetes care processes, medication adherence, glycemic and cardiovascular risk factor control, and resource utilization in nonurban practices in the Midwestern United States. Upon completion of this trial, the investigators will have new knowledge about both the effectiveness of diabetes decision aids in nonacademic nonurban practices and about the processes that promote or inhibit the successful implementation of patient decision aids in such practices.

Interventions

  • OTHER Diabetes Medication Choice Decision Aid
  • OTHER Statin Choice Decision Aid
  • OTHER Usual care for lipid therapy medication
  • OTHER Usual care for antihyperglycemic medication

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2010-04
Est. Completion 2013-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01029288

The ClinicalTrials.gov registry entry for NCT01029288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Diabetes Medication Choice Decision Aid is the first listed.

NCT01029288 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01029288 about?

NCT01029288 is a clinical study titled "Impact of Decision Aids to Enhance Shared Decision Making for Diabetes". The proposed trial seeks to determine the impact of patient decision aids versus usual care on measures of patient involvement in decision-making, diabetes care processes, medication adherence, glycemic and cardiovascular risk factor control, and resource utilization in nonurban practices in the Mid...

What is the current status of trial NCT01029288?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2010-04. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01029288?

The interventions under investigation include: Diabetes Medication Choice Decision Aid (OTHER), Statin Choice Decision Aid (OTHER), Usual care for lipid therapy medication (OTHER), Usual care for antihyperglycemic medication (OTHER).

Who is sponsoring clinical trial NCT01029288?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.